4BIO Capital strengthens investment leadership with appointment of Therese Liechtenstein as Partner and Tetsu Maruyama ...
Thera Liechtenstein brings extensive biotech investment and company‑building experience to new role as Partner at 4BIO Capital Tetsu Maruyama, former Head of Drug Discovery at Takeda Pharmaceuticals, appointed as Venture Partner London, United Kingdom, 30 …